GeoPharma, Inc. (NASDAQ: GORX), a bio-pharmaceutical company with a diversified business model comprising three main market segments - specialty pharmaceuticals, manufacturing and distribution - recently announced the expansion of the company’s distribution agreement with Cura Pharmaceutical Co., a New Jersey-based pharmaceutical marketing company that focuses on select niche markets through the offering of specialty products and services. Under the new aspects of the agreement, two new regional partners will be allowed to distribute Mucotrol™, an FDA-approved medical device, in India, Nepal, Bangladesh, Sri Lanka and South Korea.